Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Clinical Trial
Official title:
Fatty Acid Oxidation and Body Weight Regulation in Long-chain Fatty Acid Oxidation Disorders.
Verified date | April 2020 |
Source | Oregon Health and Science University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study also determines if eating a diet higher in protein alters body composition, energy balance and metabolic control among patients with a long-chain fatty acid oxidation disorder.
Status | Completed |
Enrollment | 13 |
Est. completion date | January 2010 |
Est. primary completion date | September 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 45 Years |
Eligibility |
Inclusion Criteria: - diagnosis of a long-chain fatty acid oxidation disorder including VLCAD, CPT2, LCHAD or TFP deficiency - 7 years old or greater - able to comply with diet guidelines Exclusion Criteria: - pregnant - enrolled in another study that alters diet composition - cannot complete treadmill exercise study |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Energy Expenditure | does energy expenditure and substrate oxidation differ between subjects randomized to the high carbohydrate versus the high protein diet? We measured resting energy expenditure with indirect calorimetry and estimated substrate oxidation with indirect calorimetry results and urine urea nitrogen excretion. We also measured total energy expenditure with doubly labeled water. | change from baseline after 4 months of treatment | |
Secondary | Body Composition | does body composition change more among subjects randomized to the high protein diet compared to the high carbohydrate diet? We measured body composition at baseline and again at the end of the study by DEXA - dual energy x-ray absorptiometry. | change from baseline to 4 months of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
Recruiting |
NCT05910151 -
Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Active, not recruiting |
NCT02635269 -
Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
|
N/A | |
Completed |
NCT02517307 -
Fatty Acid Oxidation Defects and Insulin Sensitivity
|
N/A | |
Completed |
NCT05411835 -
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
|
Early Phase 1 |